期刊文献+

常规急诊及尿激酶溶栓失败后补救性冠脉介入治疗急性心肌梗死的疗效 被引量:7

Therapeutic effect of routine emergency and remedial percutaneous coronary intervention on patients with acute ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的:评价急性ST段抬高型心肌梗死(STEMI)常规急诊及尿激酶溶栓失败后行补救性经皮冠状动脉介入治疗(PCI)的近期疗效及安全性。方法:回顾分析2006年6月~2009年12月在我院因急性STEMI而行急诊PCI术的134例患者的基本资料(包括溶栓失败行急诊补救性PCI患者),及其术后30d内的主要终点事件(包括全因死亡、再梗死)以及严重出血性并发症的发生情况。结果:急诊PCI术患者共计134例,其中17例(12.68%)因外院尿激酶溶栓失败转入我院行补救性PCI。134例中30d内共7例(5.22%)发生主要终点事件,死亡6例(4.48%)。多因素Logistic分析显示冠状动脉TIMI血流≤1级和主要终点事件明显相关(OR=60.98,P<0.05)。3例(2.24%)发生严重出血性并发症。单因素Logistic分析显示补救性PCI术与严重出血并发病无显著相关(P>0.05)。结论:急性ST段抬高型心肌梗死尿激酶溶栓失败后行补救性经皮冠状动脉介入治疗安全、有效。 Objective: To evaluate short-term efficacy and safety of routine emergency and remedial percutaneous coronary intervention (PCI) after failed urokinase thrombolysis in patients with acute ST-segment elevation myocar- dial infarction (STEMI). Methods.. Basic data (including patients undergoing routine emergency and remedial PCI), main endpoint events within 30d after PCI and occurrence of severe hemorrhage complications were retrospectively analyzed in all patients undergoing emergency PCI in our hospital from Jun 2006 to Dec 2009. Results.. A total of 134 patients underwent emergency PCI, among which 17 cases (12.68%) were transferred to our hospital for reme- dial PCI due to failed urokinase thrombolysis in other hospitals. Within 30d after PCI, there were seven cases (5.22 %) occurred main endpoint events and six cases (4. 48% ) died. Multiple factor Logistic analysis indicated that coronary artery TIMI blood flow ≤grade 1 was significantly correlated with main endpoint events (OR = 60.98, P 〈0.05). There were three cases (2.24%) occurring severe hemorrhage complications. Single factor Logistic analy- sis indicated that severe hemorrhage complications were not significantly correlated with remedial PCI (P〉0.05 all). Conclusion: It's safe and effective to perform remedial PCI after failed urokinase thrombolysis in patients with acute ST-segment elevation myocardial infarction.
出处 《心血管康复医学杂志》 CAS 2013年第1期54-57,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 上海市卫生局青年科研基金(2009Y130)
关键词 心肌梗塞 血管成形术 经腔 经皮冠状动脉 尿纤溶酶原激活物 Myocardial infarction Angioplasty, transluminal, percutaneous coronary Urinary plasminogen activator
  • 相关文献

参考文献9

  • 1Kushner FG,Hand M,Smith SC Jr. 2009 focused updates:ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update):A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli[J].Journal of the American College of Cardiology,2009,(23):2205-2241.
  • 2Bovill EG,Terrin ML,Stump DC. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator,heparin,and aspirin for acute myocardial infarction:Results of the Thrombolysis in Myocardial Infarction (TIMI),Phase ⅡTrial[J].Annals of Internal Medicine,1991,(04):256-265.
  • 3B(a)r F,Vainer J,Stevenhagen J. Ten year experience with early angioplasty in 759 patients with acute myocardial infarction[J].Journal of the American College of Cardiology,2000,(01):51-58.doi:10.1016/S0735-1097(00)00718-X.
  • 4Moreno R,Garcia E,Abeytua M. Coronary stenting during rescue angioplasty after failed thrombolysis[J].Catheter CardiovascIntev,1999,(01):1-5.doi:10.1002/(SICI)1522-726X(199905)47:1&lt;1::AID-CCD1&gt;3.0.CO;2-2.
  • 5Polo(n)ski L,Gasior M,Wasilewski K. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction[J].American Heart Journal,2003,(05):855-861.
  • 6杨波,张恒义,张明.急性心肌梗塞溶栓后早期介入治疗的疗效[J].心血管康复医学杂志,2005,14(3):230-230. 被引量:5
  • 7Belle L,Fourny M,Reynaud T. Efficacy and safety of glycoprotein Ⅱ b/Ⅲ a receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis[J].Catheter Cardiovascr Interv,2011,(03):376-384.
  • 8Coulter SA,Cannon CP,Ault KA. High levels of platelet inhibition with abciximab despite heightened platelct activation and aggregation during thrombolysis for acute myocardial infarc tion:results from TIMI (thrombolysis in myocardial infarction)14[J].Circulation,2000,(23):26902695.
  • 9Eisenberg PR,Sobel BE,Jaffe AS. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator[J].Journal of the American College of Cardiology,1992,(05):1065-1069.

共引文献4

同被引文献78

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部